{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T19:32:14Z","timestamp":1770492734648,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s13577-022-00725-1","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T18:31:28Z","timestamp":1654713088000},"page":"1234-1247","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Long non-coding RNA TRIM52-AS1 sponges microRNA-577 to facilitate diffuse large B cell lymphoma progression via increasing TRIM52 expression"],"prefix":"10.1007","volume":"35","author":[{"given":"Fang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shucheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,8]]},"reference":[{"key":"725_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ctrv.2018.01.002","volume":"65","author":"K Dunleavy","year":"2018","unstructured":"Dunleavy K, Erdmann T, Lenz G. Targeting the B-cell receptor pathway in diffuse large B-cell lymphoma. Cancer Treat Rev. 2018;65:41\u20136.","journal-title":"Cancer Treat Rev"},{"issue":"12","key":"725_CR2","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.3390\/cancers13122893","volume":"13","author":"N Yanguas-Casas","year":"2021","unstructured":"Yanguas-Casas N, Pedrosa L, Fernandez-Miranda I, Sanchez-Beato M. An overview on diffuse large B-cell lymphoma models: towards a functional genomics approach. Cancers (Basel). 2021;13(12):2893. https:\/\/doi.org\/10.3390\/cancers13122893","journal-title":"Cancers (Basel)."},{"key":"725_CR3","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S1470-2045(11)70235-2","volume":"12","author":"M Pfreundschuh","year":"2011","unstructured":"Pfreundschuh M, Kuhnt E, Trumper L, et al. CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group. Lancet Oncol. 2011;12:1013\u201322.","journal-title":"Lancet Oncol"},{"key":"725_CR4","doi-asserted-by":"crossref","unstructured":"Jiang J, Mei J, Ma Y, et al. Tumor hijacks macrophages and microbiota through extracellular vesicles. Exploration. 2022; p. 20210144.","DOI":"10.1002\/EXP.20210144"},{"issue":"6174\u201392","key":"725_CR5","volume":"184","author":"Y Markaki","year":"2021","unstructured":"Markaki Y, Gan Chong J, Wang Y, et al. Xist nucleates local protein gradients to propagate silencing across the X chromosome. Cell. 2021;184(6174\u201392): e32.","journal-title":"Cell"},{"issue":"2","key":"725_CR6","doi-asserted-by":"publisher","first-page":"968","DOI":"10.3390\/ijms23020968","volume":"23","author":"MW Faber","year":"2022","unstructured":"Faber MW, Vo TV. Long RNA-mediated chromatin regulation in fission yeast and mammals. Int J Mol Sci. 2022;23(2):968. https:\/\/doi.org\/10.3390\/ijms23020968","journal-title":"Int J Mol Sci"},{"key":"725_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.730014","volume":"9","author":"T Wang","year":"2021","unstructured":"Wang T, Li J, Yang L, Wu M, Ma Q. The role of long non-coding RNAs in human imprinting disorders: prospective therapeutic targets. Front Cell Dev Biol. 2021;9: 730014.","journal-title":"Front Cell Dev Biol"},{"key":"725_CR8","doi-asserted-by":"publisher","first-page":"5232","DOI":"10.1038\/s41467-021-25552-0","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhang P, Wu Q, et al. Long non-coding RNA NR2F1-AS1 induces breast cancer lung metastatic dormancy by regulating NR2F1 and DeltaNp63. Nat Commun. 2021;12:5232.","journal-title":"Nat Commun"},{"key":"725_CR9","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1038\/s41375-021-01307-0","volume":"35","author":"M Gourvest","year":"2021","unstructured":"Gourvest M, De Clara E, Wu HC, et al. A novel leukemic route of mutant NPM1 through nuclear import of the overexpressed long noncoding RNA LONA. Leukemia. 2021;35:2784\u201398.","journal-title":"Leukemia"},{"issue":"3","key":"725_CR10","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1534\/genetics.112.146704","volume":"193","author":"JT Kung","year":"2013","unstructured":"Kung JT, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future. Genetics. 2013;193(3):651\u201369. https:\/\/doi.org\/10.1534\/genetics.112.146704","journal-title":"Genetics"},{"key":"725_CR11","doi-asserted-by":"crossref","unstructured":"Zhou J, Zhang Z, Joseph J, et al. Biomaterials and nanomedicine for bone regeneration: progress and future prospects. Exploration. 2021; p. 20210011.","DOI":"10.1002\/EXP.20210011"},{"key":"725_CR12","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1080\/10428194.2021.1876866","volume":"62","author":"Y Tian","year":"2021","unstructured":"Tian Y, Li L, Lin G, et al. lncRNA SNHG14 promotes oncogenesis and immune evasion in diffuse large-B-cell lymphoma by sequestering miR-152-3p. Leuk Lymphoma. 2021;62:1574\u201384.","journal-title":"Leuk Lymphoma"},{"key":"725_CR13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/carcin\/bgab013","volume":"42","author":"Y Huang","year":"2021","unstructured":"Huang Y, Lin Y, Song X, Wu D. LINC00857 contributes to proliferation and lymphomagenesis by regulating miR-370-3p\/CBX3 axis in diffuse large B-cell lymphoma. Carcinogenesis. 2021;42:733\u201341.","journal-title":"Carcinogenesis"},{"key":"725_CR14","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.eururo.2013.12.003","volume":"65","author":"ES Martens-Uzunova","year":"2014","unstructured":"Martens-Uzunova ES, Bottcher R, Croce CM, Jenster G, Visakorpi T, Calin GA. Long noncoding RNA in prostate, bladder, and kidney cancer. Eur Urol. 2014;65:1140\u201351.","journal-title":"Eur Urol"},{"key":"725_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12943-018-0870-5","volume":"17","author":"H Liang","year":"2018","unstructured":"Liang H, Yu T, Han Y, et al. LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression. Mol Cancer. 2018;17:119.","journal-title":"Mol Cancer"},{"issue":"2","key":"725_CR16","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3390\/ijms19020570","volume":"19","author":"M Morlando","year":"2018","unstructured":"Morlando M, Fatica A. Alteration of epigenetic regulation by long noncoding RNAs in cancer. Int J Mol Sci. 2018;19(2):570. https:\/\/doi.org\/10.3390\/ijms19020570","journal-title":"Int J Mol Sci"},{"key":"725_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13148-017-0398-3","volume":"9","author":"AM Herrera-Solorio","year":"2017","unstructured":"Herrera-Solorio AM, Armas-Lopez L, Arrieta O, Zuniga J, Pina-Sanchez P, Avila-Moreno F. Histone code and long non-coding RNAs (lncRNAs) aberrations in lung cancer: implications in the therapy response. Clin Epigenet. 2017;9:98.","journal-title":"Clin Epigenet"},{"key":"725_CR18","first-page":"2567","volume":"25","author":"M Tian","year":"2021","unstructured":"Tian M, Li Y, Zheng W, et al. LncRNA PCAT1 enhances cell proliferation, migration and invasion by miR-508-3p\/NFIB axis in diffuse large B-cell lymphoma. Eur Rev Med Pharmacol Sci. 2021;25:2567\u201376.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"725_CR19","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.2147\/CMAR.S299715","volume":"13","author":"H Zeng","year":"2021","unstructured":"Zeng H, Wei Y, Wei X, Feng R. LINC00908 promotes diffuse large B-cell lymphoma development by down-regulating miR-671-5p. Cancer Manag Res. 2021;13:3589\u201399.","journal-title":"Cancer Manag Res"},{"key":"725_CR20","doi-asserted-by":"publisher","first-page":"72182","DOI":"10.18632\/oncotarget.20053","volume":"8","author":"Y Wang","year":"2017","unstructured":"Wang Y, Zhang M, Xu H, et al. Discovery and validation of the tumor-suppressive function of long noncoding RNA PANDA in human diffuse large B-cell lymphoma through the inactivation of MAPK\/ERK signaling pathway. Oncotarget. 2017;8:72182\u201396.","journal-title":"Oncotarget"},{"key":"725_CR21","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.bbrc.2019.01.105","volume":"510","author":"X Shi","year":"2019","unstructured":"Shi X, Cui Z, Liu X, et al. LncRNA FIRRE is activated by MYC and promotes the development of diffuse large B-cell lymphoma via Wnt\/beta-catenin signaling pathway. Biochem Biophys Res Commun. 2019;510:594\u2013600.","journal-title":"Biochem Biophys Res Commun"},{"key":"725_CR22","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1038\/leu.2014.126","volume":"28","author":"L Sehgal","year":"2014","unstructured":"Sehgal L, Mathur R, Braun FK, et al. FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma. Leukemia. 2014;28:2376\u201387.","journal-title":"Leukemia"},{"key":"725_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11010-019-03588-7","volume":"461","author":"H Cheng","year":"2019","unstructured":"Cheng H, Yan Z, Wang X, et al. Downregulation of long non-coding RNA TUG1 suppresses tumor growth by promoting ubiquitination of MET in diffuse large B-cell lymphoma. Mol Cell Biochem. 2019;461:47\u201356.","journal-title":"Mol Cell Biochem"},{"key":"725_CR24","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.3892\/mmr.2016.4908","volume":"13","author":"Z Liu","year":"2016","unstructured":"Liu Z, Yan HY, Xia SY, Zhang C, Xiu YC. Downregulation of long non-coding RNA TRIM52-AS1 functions as a tumor suppressor in renal cell carcinoma. Mol Med Rep. 2016;13:3206\u201312.","journal-title":"Mol Med Rep"},{"key":"725_CR25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2147\/CMAR.S286205","volume":"13","author":"Y Liu","year":"2021","unstructured":"Liu Y, Wu Y, Liu S, Dai Y. Long non-coding RNA TRIM52-AS1 promotes growth and metastasis via miR-218-5p\/ROBO1 in hepatocellular carcinoma. Cancer Manag Res. 2021;13:547\u201358.","journal-title":"Cancer Manag Res"},{"key":"725_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/cbr.2019.3271","volume":"36","author":"C Zhou","year":"2021","unstructured":"Zhou C, Chen Z, Peng C, Chen C, Li H. Long noncoding RNA TRIM52-AS1 sponges miR-514a-5p to facilitate hepatocellular carcinoma progression through increasing MRPS18A. Cancer Biother Radiopharm. 2021;36:211\u20139.","journal-title":"Cancer Biother Radiopharm"},{"key":"725_CR27","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/cam4.2675","volume":"9","author":"G Bao","year":"2020","unstructured":"Bao G, Huang J, Pan W, Li X, Zhou T. Long noncoding RNA CERS6-AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA. Cancer Med. 2020;9:278\u201389.","journal-title":"Cancer Med"},{"key":"725_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcancer.2014.07.006","volume":"29","author":"M Lederer","year":"2014","unstructured":"Lederer M, Bley N, Schleifer C, Huttelmaier S. The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer. Semin Cancer Biol. 2014;29:3\u201312.","journal-title":"Semin Cancer Biol"},{"key":"725_CR29","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1007\/s13577-021-00518-y","volume":"34","author":"JF Wang","year":"2021","unstructured":"Wang JF, Xi ZN, Su HJ, Bao Z, Qiao YH. SP1-induced overexpression of LINC00520 facilitates non-small cell lung cancer progression through miR-577\/CCNE2 pathway and predicts poor prognosis. Hum Cell. 2021;34:952\u201364.","journal-title":"Hum Cell"},{"key":"725_CR30","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13048-020-00721-9","volume":"13","author":"J Xu","year":"2020","unstructured":"Xu J, Zhang P, Sun H, Liu Y. LINC01094\/miR-577 axis regulates the progression of ovarian cancer. J Ovarian Res. 2020;13:122.","journal-title":"J Ovarian Res"},{"key":"725_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.709816","volume":"12","author":"S Hou","year":"2021","unstructured":"Hou S, Chen D, Liu J, et al. Profiling and molecular mechanism analysis of long non-coding RNAs and mRNAs in pulmonary arterial hypertension rat models. Front Pharmacol. 2021;12: 709816.","journal-title":"Front Pharmacol"},{"key":"725_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110507","volume":"129","author":"S Ghafouri-Fard","year":"2020","unstructured":"Ghafouri-Fard S, Eghtedarian R, Taheri M. The crucial role of non-coding RNAs in the pathophysiology of inflammatory bowel disease. Biomed Pharmacother. 2020;129: 110507.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"725_CR33","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1007\/s10072-021-05408-7","volume":"42(10)","author":"E Taghizadeh","year":"2021","unstructured":"Taghizadeh E, Gheibihayat SM, Taheri F, Afshani SM, Farahani N, Saberi A. LncRNAs as putative biomarkers and therapeutic targets for Parkinson\u2019s disease. Neurol Sci. 2021;42(10):4007\u201315. https:\/\/doi.org\/10.1007\/s10072-021-05408-7","journal-title":"Neurol Sci"},{"key":"725_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.665811","volume":"12","author":"VS Tanwar","year":"2021","unstructured":"Tanwar VS, Reddy MA, Natarajan R. Emerging role of long non-coding RNAs in diabetic vascular complications. Front Endocrinol (Lausanne). 2021;12: 665811.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"725_CR35","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12935-021-02013-8","volume":"21","author":"J He","year":"2021","unstructured":"He J, Ling L, Liu Z, et al. Functional interplay between long non-coding RNAs and the Wnt signaling cascade in osteosarcoma. Cancer Cell Int. 2021;21:313.","journal-title":"Cancer Cell Int"},{"key":"725_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114657","volume":"190","author":"YA Uthman","year":"2021","unstructured":"Uthman YA, Ibrahim KG, Abubakar B, et al. MALAT1: A promising therapeutic target for the treatment of metastatic colorectal cancer. Biochem Pharmacol. 2021;190: 114657.","journal-title":"Biochem Pharmacol"},{"key":"725_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188584","volume":"1876","author":"AV Zamaraev","year":"2021","unstructured":"Zamaraev AV, Volik PI, Sukhikh GT, Kopeina GS, Zhivotovsky B. Long non-coding RNAs: a view to kill ovarian cancer. Biochim Biophys Acta Rev Cancer. 2021;1876: 188584.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"725_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.657965","volume":"11","author":"AA Farooqi","year":"2021","unstructured":"Farooqi AA, Nayyab S, Martinelli C, et al. Regulation of hippo, TGFbeta\/SMAD, Wnt\/beta-catenin, JAK\/STAT, and NOTCH by long non-coding RNAs in pancreatic cancer. Front Oncol. 2021;11: 657965.","journal-title":"Front Oncol"},{"key":"725_CR39","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.bbagrm.2014.08.012","volume":"1839","author":"G Yang","year":"2014","unstructured":"Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochim Biophys Acta. 2014;1839:1097\u2013109.","journal-title":"Biochim Biophys Acta"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-022-00725-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-022-00725-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-022-00725-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T17:19:29Z","timestamp":1656004769000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-022-00725-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,8]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["725"],"URL":"https:\/\/doi.org\/10.1007\/s13577-022-00725-1","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,8]]},"assertion":[{"value":"7 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Research Ethics Committee of Cangzhou Central Hospital (2017-CZ-012). All the patients signed the informed consent before participating in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}